BE721891A - - Google Patents

Info

Publication number
BE721891A
BE721891A BE721891DA BE721891A BE 721891 A BE721891 A BE 721891A BE 721891D A BE721891D A BE 721891DA BE 721891 A BE721891 A BE 721891A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE721891A publication Critical patent/BE721891A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BE721891D 1967-10-05 1968-10-04 BE721891A (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2125967 1967-10-05
IT1744468 1968-06-07

Publications (1)

Publication Number Publication Date
BE721891A true BE721891A (en:Method) 1969-04-04

Family

ID=26326936

Family Applications (1)

Application Number Title Priority Date Filing Date
BE721891D BE721891A (en:Method) 1967-10-05 1968-10-04

Country Status (5)

Country Link
US (1) US3705140A (en:Method)
JP (2) JPS4842633B1 (en:Method)
BE (1) BE721891A (en:Method)
FR (2) FR1592136A (en:Method)
GB (1) GB1173539A (en:Method)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2007810A1 (en:Method) * 1968-05-03 1970-01-09 Ondetti Miguel
FR2013212A1 (en:Method) * 1968-07-18 1970-03-27 Squibb & Sons Inc

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892726A (en) * 1969-05-27 1975-07-01 Squibb & Sons Inc Tyrosine-O-sulfate containing peptides
US3862301A (en) * 1973-06-18 1975-01-21 Stanley M Chernish Glucagon as a diagnostic aid in gastrointestinal radiology
US4020152A (en) * 1973-12-18 1977-04-26 Thann & Mulhouse Barium titanate and barium zirconate in radiological contrast products
JPS529529U (en:Method) * 1975-07-07 1977-01-22
DD128973B1 (de) 1976-11-29 1979-11-28 Hartmut Niedrich Verfahren zur herstellung von peptiden,die tyrosinsulfat enthalten
DE3066728D1 (en) * 1979-04-30 1984-03-29 Max Planck Gesellschaft Tyrosine derivatives, process for their production and their use in the synthesis of peptides
DE3138233A1 (de) * 1981-09-25 1983-04-07 Farmitalia Carlo Erba S.p.A., 20159 Milano Neuropsychotropisches arzneimittel
DK489683A (da) * 1982-10-27 1984-04-28 Amano Pharma Co Ltd Fremgangsmaade til fremstilling af peptider
US4769445A (en) * 1985-03-04 1988-09-06 Pennwalt Corporation Process for the solid phase synthesis of peptides which contain sulfated tyrosine
US5086042A (en) * 1985-12-19 1992-02-04 Fisons Corporation Peptides with sulfate ester groups
FR2611722B1 (fr) * 1987-03-02 1989-08-11 Inst Nat Sante Rech Med Nouveaux peptides derives de la cck8, leur preparation et les compositions pharmaceutiques qui les contiennent
US4808701A (en) * 1987-03-30 1989-02-28 Hoffmann-La Roche Inc. Cyclic peptides having appetite regulating activity
US5182263A (en) * 1988-04-25 1993-01-26 Hoffmann-La Roche Inc. Analogs of tyrosine sulfate or tyrosine phosphate containing peptides
CN113929737B (zh) * 2021-10-20 2024-07-23 中国科学院香港创新研究院再生医学与健康创新中心 一种多肽及其作为cck受体激动剂/拮抗剂的应用
CN114874305B (zh) * 2022-05-27 2023-06-02 昆明医科大学 一种泽蛙来源促神经损伤修复活性多肽hw-p3及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472832A (en) * 1966-08-09 1969-10-14 Farmaceutici Italia Peptides related to caerulein
US3488726A (en) * 1967-07-31 1970-01-06 Squibb & Sons Inc R-l-methionyl-glycyl octapeptides related to caerulein and intermediates therefor
US3579494A (en) * 1968-07-18 1971-05-18 Squibb & Sons Inc C-sulfonated tyrosyl peptides related to cholecystokinin-pan-creozymin (cck-pz)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2007810A1 (en:Method) * 1968-05-03 1970-01-09 Ondetti Miguel
FR2013212A1 (en:Method) * 1968-07-18 1970-03-27 Squibb & Sons Inc

Also Published As

Publication number Publication date
GB1173539A (en) 1969-12-10
FR8244M (en:Method) 1970-10-05
US3705140A (en) 1972-12-05
DE1800129B2 (de) 1975-07-03
FR1592136A (en:Method) 1970-05-11
JPS5130069B1 (en:Method) 1976-08-30
DE1800129A1 (de) 1969-05-08
JPS4842633B1 (en:Method) 1973-12-13

Similar Documents

Publication Publication Date Title
FR1592136A (en:Method)
FR8212M (en:Method)
BE711772A (en:Method)
BE711505A (en:Method)
BE706532A (en:Method)
BE694260A (en:Method)
BE699232A (en:Method)
BE698676A (en:Method)
BE697418A (en:Method)
BE710487A (en:Method)
BE709130A (en:Method)
BE708873A (en:Method)
BE700504A (en:Method)
BE701110A (en:Method)
BE705443A (en:Method)
BE709701A (en:Method)
BE708726A (en:Method)
BE708989A (en:Method)
BE700981A (en:Method)
BE700337A (en:Method)
BE706372A (en:Method)
BE707071A (en:Method)
BE700586A (en:Method)
BE699318A (en:Method)
BE700616A (en:Method)

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SOCIETA FARMACEUTICI ITALIA

Effective date: 19861031